Aldeyra Therapeutics Inc — Quarterly Cash Flow (NASDAQ:ALDX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 117.32 M104.61 M93.2 M84.96 M77.8 M Total liabilities 32.22 M33.6 M29.6 M29.67 M28.56 M Total equity 85.1 M71 M63.6 M55.29 M49.24 M Total liabilities & shareholders' equities 117.32 M104.61 M93.2 M84.96 M77.8 M Total debt ————— Net debt —————

Notizie

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

I migliori titoli sanitari per quest’anno secondo BTIG

Top Healthcare Stocks for This Year According to BTIG

Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know

Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?

Il direttore dello sviluppo di Aldeyra Therapeutics lascerà entro marzo 2026

Aldeyra Therapeutics chief development officer to step down by March 2026

Aldeyra Therapeutics: Reproxalap’s March 2026 FDA Decision Is The Defining Catalyst

Disoccupazione USA oltre la attese, Wall Street vira in positivo

Why Is Aldeyra Therapeutics Stock Falling Tuesday? - Aldeyra Therapeutics (NASDAQ:ALDX)

Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Adagio Medical Holdings (NASDAQ:ADGM), Aldeyra Therapeutics (NASDAQ:ALDX)

Aldeyra Therapeutics, Inc. (ALDX) Discusses Expansion of RASP Platform Into CNS Diseases and Update on Reproxalap for Dry Eye - Slideshow (NASDAQ:ALDX) 2025-11-16